ESG Data

Data related to ESG (Environment, Social, Governance)
Scope of Report: PeptiDream (PD), PDRadiopharma (PDR)

Data（Environment）
Independent Verification Statement
Data（Society）
Data（Governance）

You can see the table by scrolling horizontally.

Environment

	Scope of Report	FY2020	FY2021	*FY2022^1**	FY2023	FY2024	Remark
CO₂ Emissions
Scope1	PD	0 t-CO₂	0 t-CO₂	0 t-CO₂	0.06 t-CO₂	0t-CO₂
	PDR	－	－	0 t-CO₂	3,156 t-CO₂	3,271t-CO₂
Scope2	Market base
	PD	1,381 t-CO₂	1,327 t-CO₂	0 t-CO₂	0 t-CO₂	0t-CO₂
	PDR	－	－	6,385 t-CO₂	7,343 t-CO₂	6,898t-CO2
	Location base
	PD	－	－	－	1,595 t-CO₂	1,690t-CO2
	PDR	－	－	－	8,121 t-CO₂	8,000t-CO2
Scope3
Category1	PD	－	－	－	11,316 t-CO₂	65,506t-CO₂
	PDR	－	－	－	59,567 t-CO₂	65,506t-CO₂
Category2	PD	－	－	－	4,720 t-CO₂	7,408t-CO₂
	PDR	－	－	－	4,720 t-CO₂	7,408t-CO₂
Category３	PD	201 t-CO₂	227 t-CO₂	0 t-CO₂	248 t-CO₂	3,589t-CO₂
	PDR	－	－	－	1,901 t-CO₂	3,589t-CO₂
Category4	PD	－	－	－	192 t-CO₂	23,006t-CO₂
	PDR	－	－	－	18,270 t-CO₂	23,006t-CO₂
Category5	PD	－	－	－	212 t-CO₂	296t-CO₂
	PDR	－	－	－	107 t-CO₂	296t-CO₂
Category6	PD	－	－	－	28 t-CO₂	95t-CO₂
	PDR	－	－	－	66 t-CO₂	95t-CO₂
Category7	PD	35 t-CO₂	41 t-CO₂	46t-CO₂	48 t-CO₂	227t-CO₂
	PDR	－	－	－	172 t-CO₂	227t-CO₂
Category11	PD	ー	ー	ー	ー	38t-CO₂
	PDR	ー	ー	ー	ー	38t-CO₂
Category12	PD	ー	ー	ー	ー	18t-CO₂
	PDR	ー	ー	ー	ー	18t-CO₂
Category14	PD	ー	ー	ー	ー	0t-CO₂
	PDR	ー	ー	ー	ー	0t-CO₂
Category15	PD	ー	ー	ー	ー	277t-CO₂
	PDR	ー	ー	ー	ー	277t-CO₂
CO₂ Emissions per Employee(Scope1,2)	PD	9.21 t-CO₂	7.72 t-CO₂	0 t-CO₂	0 t-CO₂	0t-CO₂
	PDR	－	－	20 t-CO₂	21 t-CO₂	22t-CO₂
No. of Employees	PD	150	172	196	206	217
	PDR	－	－	414	450	464
Energy Consumption	PD Group	2,946,014kWh	3,325,735kWh	17,747,020kWh	22,183,649kWh	22,856,540kWh
of which, renewable electricty purchase	PD Group	ー	ー	3,373,907kWh	3,642,317kWh	6,905,273kWh	*Renewable electricity represents 30% of all energy consumption
	PD	2,946,014kWh	3,325,735kWh	3,373,907kWh	3,642,317kWh	3,994,619kWh
of which, renewable electricty purchase	PD	ー	ー	3,373,907kWh	3,642,317kWh*	3,994,619kWh*	*Renewable electricity represents 100% of all energy consumption
	PDR	ー	ー	14,373,113kWh	18,541,332kWh	18,911,921kWh
of which, renewable electricty purchase	PDR	ー	ー	ー	ー	2,910,654kWh*	*Renewable electricity represents 15% of all energy consumption
Water Comsumption	PD	5,312㎥	6,180㎥	5,896㎥	5,354㎥	5,516㎥
	PDR	－	－	53,430㎥	65,743㎥	70,123㎥
Water Emissions	PD	5,312㎥	6,180㎥	5,896㎥	5,354㎥	5,516㎥
	PDR	－	－	18,117㎥	24,068㎥	25,927㎥
of which, processed in wastewater treatment facilities	PD	591.0㎥	740.3㎥	599.6㎥	523.0㎥	547.2㎥
	PDR	－	－	－	－	ー
Pollutant^*2 Concentration（annual average）
Biochemical Oxygen Demand（BOD）	PD	29.8㎎/L	34.1㎎/L	27.0㎎/L	27.3㎎/L	26.3㎎/L
	PDR (Chiba Factory)	－	－	1.1㎎/L	1.1㎎/L	1.0㎎/L
	PDR (Kawasaki PET Lab)	－	－	5.8㎎/L	7.8㎎/L	5.5㎎/L
	PDR (Ibaraki PET Lab)	－	－	9.1㎎/L	less than 5.0㎎/L	Less than5.0㎎/L
Suspended Solids（SS）	PD	25.6㎎/L	27.5㎎/L	16.5㎎/L	18.58㎎/L	13.8㎎/L
	PDR (Chiba Factory)	－	－	less than 1㎎/L	less than 1㎎/L	Less than 1㎎/L
	PDR (Kawasaki PET Lab)	－	－	less than10㎎/L	15.3㎎/L	13.4㎎/L
	PDR (Ibaraki PET Lab)	－	－	less than10㎎/L	10.3㎎/L	10.3㎎/L
Pollution load^*2（annual）
Biochemical Oxygen Demand（BOD）in Water	PD	22.7kg	32.4kg	28.1kg	24.8kg	25.5kg
	PDR (Chiba Factory)	－	－	19.0kg	24.9kg	25.0kg
	PDR (Kawasaki PET Lab)	－	－	2.3kg	5.1kg	3.7kg
	PDR (Ibaraki PET Lab)	－	－	4.2kg	3.9kg	3.6kg
Suspended Solids（SS）in Water	PD	27.1kg	29.8kg	13.6kg	11.1kg	10.9kg
	PDR (Chiba Factory)	－	－	17.3kg	22.7kg	24.5kg
	PDR (Kawasaki PET Lab)	－	－	4.0kg	10.0kg	10.2kg
	PDR (Ibaraki PET Lab)	－	－	4.7kg	8.1kg	7.5kg
Waste Emissions^*2	PD	102.4 tons	119.4 tons	118.5 tons	122.4 tons	123.4 tonnes
	PDR	－	－	139.0 tons	138.5 tons	130.1 tonnes
of which, operational (Industrial) waste^*3	PD	93.0 tons	109.5 tons	112.4 tons	106.8 tons	106.5 tonnes
	PDR	－	－	61.1 tons	50.8 tons	51.2 tonnes
of which, general waste (office)	PD	9.4 tons	9.9 tons	6.1 tons	8.9 tons	9.5 tonnes
	PDR	－	－	30.9 tons	47.6 tons	46.1 tonnes
Amount of recycled	PD	4.6 tons	6.8 tons	7.0 tons	6.7 tons	7.4 tonnes
	PDR	－	－	47.0 tons	40.1 tons	32.8 tonnes
No. of administrative penalties and litigations related to the environment	PD	0	0	0	0	0
	PDR	－	－	0	0	0

*1 Since PDRadiopharma was integrated in March 2022, the fiscal year ending December 2022 consists of 9 months from April 1 to December 31.

*2 Due to a change in definition in FY2023, the figures for FY2022 have been retroactively adjusted.

*3 Excludes PDRadiopharma's radioactive waste from radionuclides

Related Links

Social

	Scope of Report	FY2020	FY2021	*FY2022^1**	FY2023	FY2024
<Employee Data>
No. of employees^*2	PD	150	172	196	206	217
	PDR	－	－	414	450	464
No. of employees involved in R&D^*3	PD	133	156	172	184	195
	PDR	－	－	36	44	43
Ratio of employees involved in R&D^*3	PD	88.7%	90.7%	87.8%	89.3%	89.9%
	PDR	－	－	10.2%	9.8%	9.3%
of which, Female	PD	57	61	77	81	77
	PDR	－	－	82	85	90
Ratio of female employees	PD	38.0%	35.5%	39.3%	39.3%	35.5%
	PDR	－	－	19.8%	18.9%	19.4%
of which, non-Japanese	PD	4	2	3	3	4
	PDR	－	－	0	0	1
Ratio of non-Japanese employees	PD	2.7%	1.2%	1.5%	1.5%	1.8%
	PDR	－	－	0.0%	0.0%	0.2%
No. of full-time employees	PD	128	142	155	153	157
	PDR	－	－	352	395	404
of which, Female	PD	45	40	45	45	41
	PDR	－	－	73	78	81
Ratio of female employees	PD	35.2%	28.2%	29.0%	29.4%	26.1%
	PDR	－	－	20.7%	19.7%	20.0%
No. of managerial employees^*4	PD	32	38	43	50	61
	PDR	－	－	218	214	216
of which, Female	PD	6	7	8	8	11
	PDR	－	－	34	35	37
Ratio of female in managerial positions	PD	18.8%	18.4%	18.6%	16.0%	18.0%
	PDR	－	－	15.6%	16.4%	17.1%
No. of senior managerial employees	PD	19	24	29	29	30
	PDR	－	－	114	115	112
of which, Female	PD	4	6	7	7	7
	PDR	－	－	10	10	12
Ratio of female in senior managerial positions	PD	21.1%	25.0%	24.1%	24.1%	23.3%
	PDR	－	－	8.8%	8.7%	10.7%
Average age	PD	38.2	37.7	38.7	39.2	39.7
	PDR	－	－	45.2	43.9	43.7
of which, Male	PD	38.7	37.8	39.0	39.5	40.0
	PDR	－	－	45.5	43.9	43.5
of which, Female	PD	37.2	37.4	38.0	38.6	38.9
	PDR	－	－	44.2	44	44.2
Average service years	PD	3.5	3.7	4.2	4.9	5.3
	PDR	－	－	17.7	16	15.7
of which, Male	PD	3.4	3.4	4.0	4.7	5.2
	PDR	－	－	18.1	16	15.6
of which, Female	PD	3.8	4.3	4.7	5.4	5.6
	PDR	－	－	16.2	15.7	16.1
No. of hires (of which, Female)	PD	25 (4)	27 (3)	24(8)	15(5)	17(4)
	PDR	－	－	17(1)	64(9)	33(7)
No. of new graduate (of which, Female)	PD	0 (0)	6 (0)	1 (0)	0	3(0)
	PDR	－	－	2 (0)	12(2)	12(3)
Ratio of mid-careers	PD	100%	78%	96%	100%	82%
	PDR	－	－	88%	81%	63.64%
No. of retirees (of which, Female)	PD	3 (1)	14 (8)	14(4)	16(7)	14(7)
	PDR	－	－	29 (4)	24(5)	17(2)
Turnover rate	PD	2.4%	9.1%	8.2%	10.6%	9.3%
	PDR	－	－	7.1%	5.9%	3.7%
Turnover rate of hired new graduates after three years	PD	0.0%	0.0%	20.0%	0.0%	16.7%
	PDR	－	－	0.0%	0.0%	0.0%
Average annual salary（thousand yen）*^5**	PD	9,760	8,826	9,662	9,592	11,692
	PDR	－	－	5,664	7,365	6,717
Ratio of average salaries of men to women	PD	－	－	84.7%	86.0%	89.3%
	PDR	－	－	77.0%	81.0%	83.0%
No. of disabled employees	PD	4	4	5	5	5
	PDR	－	－	8	10	12
Ratio of disabled employees	PD	3.1%	2.8%	3.2%	3.3%	3.2%
	PDR	－	－	1.9%	2.2%	2.6%
Ratio of female employees who took maternity/childcare leave	PD	100%	100%	100%	100%	100%
	PDR	－	－	100%	100%	100%
Ratio of male employees who took childcare leave	PD	－	50.0%	75.0%	50.0％	66.7%
	PDR	－	－	42.9%	44.4%	36.3%
Return rate of female employees after maternity/childcare leave	PD	100%	66.7%	100%	100%	67%
	PDR	－	－	100%	100%	100%
Return rate of male employees after childcare leave	PD	－	100%	100%	100%	100%
	PDR	－	－	100%	100%	100%
No. of employees who took nursing care leave	PD	0	0	0	0	0
	PDR	－	－	0	0	0
Usage of annual paid leave	PD	67.7%	68.5%	76.5%	83.9%	86.5%
	PDR	－	－	68.8%	74.8%	71.1%
Usage of summer paid leave	PD	95.1%	96.5%	99.0%	99.5%	98.6%
Ratio of employees who underwent health checkup	PD	88.6%	97.2%	95.2%	96.5%	96.5%
	PDR	－	－	99.8%	99.5%	99.0%
Ratio of employees who participated Stress Check Program mandated by MHLW	PD	91.3%	88.2%	95.4%	98.6%	96.6%
	PDR	－	－	100%	100%	100%
Ratio of employees on leave due to mental disorders	PD	0.0%	2.3%	1.0%	1.3%	1.4%
	PDR	－	－	0.0%	0.9%	0.4%
<Diverse Core Human Resources Data>*^4**
Ratio of doctorate (Ph.D.) holders	PD	－	55.2%	51.2%	54.0%	45.0%
Female manager ratio	PD	－	18.4%	18.6%	16.0%	18.3%
Ratio of foreign employees or employees with overseas work experience	PD	－	31.5%	32.6%	32.0%	31.7%
Ratio of employees (in 20s/30s)	PD	－	15.8%	16.3%	24.0%	20.0%
<Other Society-related Data>
No. of occupational accidents	PD	1	1	0	0	1
	PDR	－	－	1	1	0
Fatalities	PD	0	0	0	0	0
	PDR	－	－	0	0	0
LTIFR (Lost Time Injury Frequency Rate)	PD	4.6%	3.7%	0.0%	0.0%	3.5%
	PDR	－	－	1.3%	1.2%	0.0%
Severity rate	PD	0.05%	0.07%	0.0%	0.0%	0.03%
	PDR	－	－	0.0%	2.0%	0.0%
OIFR (Occupational Illness Frequency Rate)	PD	0.0%	0.0%	0.0%	0.0%	0.0%
	PDR	－	－	0.0%	0.0%	0.0%
No. of administrative action and violation of laws and regulatory compliance	PD	0	0	0	0	0
	PDR	－	－	0	0	0
Political contributions（yen）	PD	0	0	0	0	0
	PDR	－	－	0	0	0
No. of whistle-blowing system hotline complaints received	PD	1	2	2	1	1
	PDR	－	－	0	0	0
No. of regulators inspections^*6	PD	－	－	－	－	－
	PDR	－	－	8	1	4
No. of warning letters, etc.^*7	PD	－	－	－	－	－
	PDR	－	－	0	0	0
Social contribution spending^*8（thousand yen）	PD	－	9,376	10,112	9,611	11,722
	PDR	－	－	114,127	146,979	63,768
Largest Contributions & Expenditures	PD	－	454	400	-	500
	PDR	－	－	114,000	146,119	62,119
Employee volunteer hours and activity expenses^*9	PD	－	8,921	9,712	9,611	11,722
	PDR	－	－	127	860	1,649

*1 Since PDRadiopharma was integrated in March 2022, the fiscal year ending December 2022 consists of 9 months from April 1 to December 31.

*2 PeptiDream：The number of full-time, contract and temporary employees. PDRadiopharma：The number of full-time, contract employees.

*3 PDRadiopharma：The number and ratio of full-time employees.

*4 The number of managerial employees includes senior managers and senior-ranking specialists.

*5 PDRadiopharma：Calculated based on total annual salary for the 9 month from April 1 to December 31, 2022.

*6 PDRadiopharma：Number of inspections and investigations conducted by PMDA and overseas regulators.

*7 Warning letters issued by the FDA or administrative guidance/improvement orders, etc.

*8 PDRadiopharma：Due to a change in definition in FY2023, the figures for FY2022 have been retroactively adjusted.

*9 Volunteer engagements, etc. converted into monetary equivalents.

	Scope of Report	FY2020	FY2021	FY2022	FY2023	FY2024
Board of Directors Total	PD	7	7	7	7	7
Female	PD	0	1	1	1	1
Board of Directors (Excluding Auditing Committee Members)	PD	4	3	3	3	3
Internal Directors	PD	4	3	3	3	3
External Directors	PD	0	0	0	0	0
Board of Directors (Auditing Committee Members)	PD	3	4	4	4	4
Independent External Directors	PD	3	4	4	4	4
Ratio of Independent External Directors	PD	42.9%	57.1%	57.1%	57.1%	57.1%
Ratio of Female Directors	PD	0,0%	14.3%	14.3%	14.3%	14.3%
Ratio of Foreign Directors	PD	14.3%	14.3%	14.3%	14.3%	14.3%
Average Age of Directors	PD	58	55	56	57	58
Meeting Frequency of Board of Directors	PD	16	23	19	21	21
Meeting Attendance Ratio	PD	97.3%	100%	98.5%	100%	100%
Meeting Frequency of Auditing Committee	PD	14	14	15	14	13
Meeting Attendance Ratio	PD	95.2%	100%	100%	100%	100%
Meeting Frequency of Nomination and Compensation Committee	PD	5	5	4	7	8
Nomination and Compensation Committee Members	PD	4	4	4	5	5
Internal Directors	PD	2	2	2	2	2
Independent External Directors	PD	2	2	2	3	3
Meeting Attendance Ratio	PD	100%	100%	93.3%	100%	100%
Remuneration of Board of Directors (in thousand yen)
Board of Directors (Excluding Auditing Committee Members)	PD	377,000	301,000	540,000	485,748	690,750
Fixed Remuneration	PD	192,000	251,500	270,000	279,450	309,150
Performance-Based Remuneration	PD	185,000	49,500	270,000	206,297	381,599
Board of Directors (Auditing Committee Members)	PD	15,600	20,865	22,620	23,468	24,644

Income tax by region (FY2024)

	Names of entities	Primary activities	Revenue	Profit(Loss) before tax	Income tax accrued	Income tax paid	Number of employees
Japan	PD	Drug Discovery and Development Business Segment	46,676	20,888	66,306	2,178	621
Japan	PDR	Radiopharmaceutical Business Segment	46,676	20,888	66,306	2,178	621
Total			46,676	20,888	66,306	2,178	621

※ Millions of Yen